Newstral
Article
The Times of India on 2020-07-04 13:06
Docs slam ICMR's deadline for launching Covaxin
Related news
- How monkeys were tracked for Covaxin trial!The Times of India
- Covaxin output cycle may hit Centre’s deadlineThe Hindu
- DCGI nod for Covaxin human trialsThe Hindu
- Covaxin data given to WHO for nodThe Hindu
- Full licence for Covaxin may take timeThe Hindu
- WHO’s approval for Covaxin likely this monthThe Hindu
- Covaxin safe for kids: Bharat BiotechThe Times of India
- Covaxin priced at ₹600 for States, ₹1,200 for private hospitalsThe Hindu
- Covaxin for children: recommendations being studied, says MinisterThe Hindu
- Corbevax, Covaxin get drug regulator nod for use in childrenThe Hindu
- BCovaxin: Concern over 'rushed' approval for India Covid jabbbc.co.uk
- MNCs tried to scuttle WHO nod for Covaxin: CJI RamanaThe Times of India
- 'Bharat Biotech yet to apply for Covaxin approval by Canada'The Times of India
- More data on Covaxin jabs for children soughtThe Hindu
- Covaxin approval: WHO seeks additional clarifications for final 'risk-benefit assessment'The Times of India
- COVID-19 | AIIMS Delhi starts screening of children for Covaxin trialsThe Hindu
- 'Delay in WHO approval for Covaxin a serious setback for India'The Times of India
- Updated data from Covaxin phase 3 trial shows 78% efficacyThe Hindu
- Drug Controller General approves Covishield and Covaxin in India for ‘emergency use’The Hindu